The liquid biopsy market is not uniform—regional demand varies based on healthcare infrastructure, cancer awareness, and regulatory support. Understanding these patterns helps vendors tailor strategies to capture growth in high-potential areas and address gaps in underserved regions. North America leads global adoption, accounting for 45% of 2023 sales. This is driven by advanced...